Company news

Quest PharmaTech Inc. news in 2019

Quest PharmaTech Inc.'s news releases, calls and decks from 2019, newest first.

View company

OncoQuest Receives "Notice of Allowance" for Patent Protection of the Administration Schedule of Oregovomab and Chemotherapy for Stage III-IV Ovarian Cancer Patients

September 25, 2019

OncoQuest Lays the Groundwork for Commencement of Phase 3 Study in Frontline Ovarian Cancer

January 25, 2019